In 2023, government expenditures on R&D health in France stood at an unspecified reference value. Forecasts from 2024 to 2028 predict a steady decline in this investment, from 0.99 in 2024 to 0.89 in 2028. Year-on-year variations indicate a consistent downward trend: approximately -2.02% in 2025, -3.09% in 2026, -3.19% in 2027, and -2.20% in 2028. The five-year average CAGR suggests a long-term decrease in government commitment to R&D health funding.

Future trends to watch for:

Potential shifts in government policy that might reverse or accelerate these trends.
Impacts of economic conditions and budgetary constraints on R&D funding allocations.
Possible increased reliance on private sector investment to offset reduced government support.